Sequent Scientific gains as its arm concludes acquisition of 70% stake in Interchange

02 Aug 2016 Evaluate

SeQuent Scientific is currently trading at Rs. 127.35, up by 0.30 points or 0.24% from its previous closing of Rs. 127.05 on the BSE.

The scrip opened at Rs. 127.05 and has touched a high and low of Rs. 129.50 and Rs. 126.15 respectively. So far 4,815 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 260.00 on 22-Dec-2015 and a 52 week low of Rs. 124.30 on 25-Aug-2015.

Last one week high and low of the scrip stood at Rs. 134.75 and Rs. 124.75 respectively. The current market cap of the company is Rs. 3,025.60 crore.

The promoters holding in the company stood at 56.25%, while Institutions and Non-Institutions held 20.67% and 23.08% respectively.

SeQuent Scientific’s subsidiary Alivira Animal Health (Alivira) has completed the acquisition of 70% stake in Interchange Veterinaria Industria E Comercio SA Brazil (Interchange). The definitive agreement for the same was signed on April 15, 2016 and was subject to customary closing conditions.

With this acquisition, Alivira has now grown to be a $ 120 million business on a run-rate basis with products being sold in 54 countries across the world. Alivira has strong formulations business in key veterinary markets of Europe, LATAM, India, Turkey, Africa and South East Asian countries. Over 80% of the revenues of Alivira are generated outside India, with manufacturing operations in Spain, Brazil, India and Turkey and R&D development in India, Turkey and Spain. Alivira has emerged as the first Global Animal Health business from India.

Acquisition of Interchange provides Alivira access to Brazil, the third largest veterinary market in the world accounting for 7.5% of the global animal health business. Estimated at $1.2 billion in 2015, Brazilian veterinary market is growing at 10.5%, which is twice the average global veterinary growth.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.


Sequent Scientific Share Price

199.65 -8.00 (-3.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×